World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   813 records for 240 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
Not recruitingYesNCT03504982
Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat
13/04/2018 
RecruitingNoNCT03447756
Titration Study of ABX-1431
09/02/2018 
AuthorisedYesEUCTR2017-004294-14-LT
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-004294-14-GR Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease 28/02/2018 
01/02/2018 
AuthorisedYesEUCTR2017-004295-55-LT
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-004295-55-GR Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease 01/03/2018 
01/02/2018 
AuthorisedYesEUCTR2017-004294-14-HU
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease
30/01/2018 
AuthorisedYesEUCTR2017-004295-55-HU
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease
30/01/2018 
RecruitingYesNCT03442725
Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function
26/01/2018 
AuthorisedYesEUCTR2017-004101-40-BG
Long-Term Study of Arbaclofen Extended-Release Tablets in Multiple Sclerosis Patients with Spasticity
09/01/2018 
RecruitingYesNCT03383211
Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers
19/12/2017 
RecruitingYesNCT03303313
A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome
25/09/2017 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history